MIRA

MIRA Pharmaceuticals (MIRA)

About MIRA Pharmaceuticals (MIRA)

MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. It engages in developing its product candidates, Ketamir-2 and MIRA-55, designed to address unmet medical needs in pain management, depression, PTSD, and cognitive function. The company was founded by Adam Kaplin on September 3, 2020 and is headquartered in Miami, FL.

Details

Daily high

$1.59

Daily low

$1.55

Price at open

$1.58

52 Week High

$2.45

52 Week Low

$0.73

Market cap

66.2M

Dividend yield

0.00%

Volume

48,267

Avg. volume

261,688

P/E ratio

-1.04

MIRA Pharmaceuticals News